Govindan R - Search Results

1

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10⁺ advanced non-small cell lung cancer.

Blumenschein GR, Devarakonda S, Johnson M, Moreno V, Gainor J, Edelman MJ, Heymach JV, Govindan R, Bachier C, Doger de Spéville B, Frigault MJ, Olszanski AJ, Lam VK, Hyland N, Navenot JM, Fayngerts S, Wolchinsky Z, Broad R, Batrakou D, Pentony MM, Sanderson JP, Gerry A, Marks D, Bai J, Holdich T, Norry E, Fracasso PM. Blumenschein GR, et al. Among authors: govindan r. J Immunother Cancer. 2022 Jan;10(1):e003581. doi: 10.1136/jitc-2021-003581. J Immunother Cancer. 2022. PMID: 35086946 Free PMC article. Clinical Trial.

2

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation.

Arquette M, Wasserman T, Govindan R, Garfield D, Senzer N, Gillenwater H, Socinski M. Arquette M, et al. Among authors: govindan r. Semin Radiat Oncol. 2002 Jan;12(1 Suppl 1):59-61. doi: 10.1053/srao.2002.31375. Semin Radiat Oncol. 2002. PMID: 11917286 Clinical Trial.

3

Phase I study of rubitecan and gemcitabine in patients with advanced malignancies.

Fracasso PM, Rader JS, Govindan R, Herzog TJ, Arquette MA, Denes A, Mutch DG, Picus J, Tan BR, Fears CL, Goodner SA, Sun SL. Fracasso PM, et al. Among authors: govindan r. Ann Oncol. 2002 Nov;13(11):1819-25. doi: 10.1093/annonc/mdf342. Ann Oncol. 2002. PMID: 12419757 Free article. Clinical Trial.

4

Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignancies.

Fracasso PM, Rodriguez LC, Herzog TJ, Fears CL, Goodner SA, Govindan R, Picus J, Rader JS, Tan BR, Arquette MA. Fracasso PM, et al. Among authors: govindan r. Cancer. 2003 Aug 1;98(3):610-7. doi: 10.1002/cncr.11547. Cancer. 2003. PMID: 12879480 Free article. Clinical Trial.

5

Cetuximab in advanced non-small cell lung cancer.

Govindan R. Govindan R. Clin Cancer Res. 2004 Jun 15;10(12 Pt 2):4241s-4244s. doi: 10.1158/1078-0432.CCR-040015. Clin Cancer Res. 2004. PMID: 15217966 Review.

6

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.

Kommareddy A, Coplin MA, Gao F, Behnken D, Romvari E, Read W, Govindan R. Kommareddy A, et al. Among authors: govindan r. Lung Cancer. 2004 Aug;45(2):221-5. doi: 10.1016/j.lungcan.2004.01.022. Lung Cancer. 2004. PMID: 15246194

7

Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status.

Govindan R, Garfield DH. Govindan R, et al. Semin Oncol. 2004 Dec;31(6 Suppl 11):27-31. doi: 10.1053/j.seminoncol.2004.10.006. Semin Oncol. 2004. PMID: 15599832 Review.

8

A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer.

Govindan R, Lim WT, Arquette MA, Goodner SA, Fears CL, Mortimer JE, Fracasso PM. Govindan R, et al. Oncol Rep. 2006 Jan;15(1):123-7. Oncol Rep. 2006. PMID: 16328044 Free article. Clinical Trial.

9

The role of docetaxel in N2 locally advanced non-small-cell lung cancer.

Pillot G, Govindan R. Pillot G, et al. Among authors: govindan r. Clin Lung Cancer. 2005 Dec;7 Suppl 3:S87-92. doi: 10.3816/clc.2005.s.016. Clin Lung Cancer. 2005. PMID: 16384542 Review.

10

Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program.

Govindan R, Natale R, Wade J, Herbst R, Krebs A, Reiling R, Hensing T, Wozniak A, Belani CP, Kelly K, Ochs J. Govindan R, et al. Lung Cancer. 2006 Sep;53(3):331-7. doi: 10.1016/j.lungcan.2006.04.013. Epub 2006 Jun 23. Lung Cancer. 2006. PMID: 16797779 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

630 results

Search Page